Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects

In conclusion, the use of the LNG-IUS for 6 months was not associated with relevant changes in clinical or metabolic variables of women with no comorbidities regardless of the presence of PCOS.

Source: Reproductive Sciences - June 14, 2016 Category: Reproduction Medicine Authors: da Silva, A. V., de Melo, A. S., Barboza, R. P., de Paula Martins, W., Ferriani, R. A., Vieira, C. S. Tags: Original Articles Source Type: research